Detalhe da pesquisa
1.
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology.
Nat Immunol
; 22(11): 1440-1451, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686860
2.
Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Nat Immunol
; 17(5): 505-513, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26998764
3.
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.
Am J Physiol Renal Physiol
; 326(1): F30-F38, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916286
4.
Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.
J Lipid Res
; 64(6): 100381, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100172
5.
Corrigendum: Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.
Nat Immunol
; 17(10): 1235, 2016 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27648549
6.
Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis.
J Biol Chem
; 296: 100120, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33234591
7.
Trans-ethnic genome-wide association study of blood metabolites in the Chronic Renal Insufficiency Cohort (CRIC) study.
Kidney Int
; 101(4): 814-823, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120996
8.
Altered HDL proteome predicts incident CVD in chronic kidney disease patients.
J Lipid Res
; 62: 100135, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634315
9.
Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease.
Int J Mol Sci
; 21(21)2020 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121167
10.
AMP-activated protein kinase activation ameliorates eicosanoid dysregulation in high-fat-induced kidney disease in mice.
J Lipid Res
; 60(5): 937-952, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862696
11.
Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
J Biol Chem
; 293(19): 7238-7249, 2018 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581235
12.
Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.
Am J Nephrol
; 48(4): 269-277, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326477
13.
Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
Arterioscler Thromb Vasc Biol
; 37(6): 1068-1075, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428219
14.
Evidence for a link between gut microbiota and hypertension in the Dahl rat.
Physiol Genomics
; 47(6): 187-97, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25829393
15.
Altered Metabolic Profile With Sodium-Restricted Dietary Approaches to Stop Hypertension Diet in Hypertensive Heart Failure With Preserved Ejection Fraction.
J Card Fail
; 21(12): 963-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497755
16.
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.
Kidney Int
; 85(5): 1214-24, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24429397
17.
The compensatory enrichment of sphingosine -1- phosphate harbored on glycated high-density lipoprotein restores endothelial protective function in type 2 diabetes mellitus.
Cardiovasc Diabetol
; 13: 82, 2014 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751283
18.
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.
J Am Soc Nephrol
; 24(11): 1901-12, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23949796
19.
AMPK mediates the initiation of kidney disease induced by a high-fat diet.
J Am Soc Nephrol
; 22(10): 1846-55, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21921143
20.
Pirfenidone for diabetic nephropathy.
J Am Soc Nephrol
; 22(6): 1144-51, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21511828